Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P13
Within normal range
vs 2Y Ago
-1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-108.37%
2024492.30%
2023103.98%
2022-39.38%
2021-0.64%
2020-2346.13%
2019-52.64%
2018-88.11%
20170.00%